metaproterenol has been researched along with Arterial Occlusive Diseases in 1 studies
Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schoenberg, AA | 1 |
| Mennicken, U | 1 |
| Simon, R | 1 |
| Brambring, P | 1 |
| Heintzen, PH | 1 |
1 other study available for metaproterenol and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Stroke volume estimation from aortic pressure with correction for arrhythmias.
Topics: Animals; Aorta; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Blood Pressure; Cardiac Output; C | 1974 |